Hypoxia-induced acute lung injury in murine models of sickle cell disease

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 286, Issue 4 30-4, 2004, Pages

  Pritchard Jr , Kirkwood A ^a,c   Ou, Jingsong ^a   Ou, Zhijun ^a   Shi, Yang ^a   Franciosi, James P ^a   Signorino, Paul ^a   Kaul, Sushma ^a   Ackland Berglund, Cathleen ^a   Witte, Karin ^a   Holzhauer, Sandra ^a   Mohandas, Narla ^b   Guice, Karen S ^a   Oldham, Keith T ^a   Hillery, Cheryl A ^a  

^a CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^b NEW YORK BLOOD CENTER   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Heat shock protein 90; Nitric oxide; Pulmonary microvascular endothelial cell; Sickle hemoglobin; Vaso occlusion; Xanthine oxidase

Indexed keywords

3 NITROTYROSINE; BETA GLOBIN; CYCLIC GMP; HEAT SHOCK PROTEIN 90; HEMOGLOBIN; NITRIC OXIDE; XANTHINE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL INTERACTION; CONTROLLED STUDY; DRUG INDUCED DISEASE; ENDOTHELIUM CELL; ERYTHROCYTE MEMBRANE; GENE EXPRESSION REGULATION; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HYPOXIA; LIPID PEROXIDATION; LUNG INJURY; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; TRANSGENE; VEIN OCCLUSION;

EID: 12144291636     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00288.2002     Document Type: Review

References (60)

1. Adachi T, Fukushima T, Usami Y, and Hirano K. Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface. Biochem J 289: 523-527, 1993.
2. Aslan M, Ryan TM, Adler B, Townes TM, Parks DA, Thompson JA, Tousson A, Gladwin MT, Patel RP, Tarpey MM, Batinic-Haberle I, White CR, and Freeman BA. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci USA 98: 15215-15220, 2001.
3. Aslan M, Thornley-Brown D, and Freeman BA. Reactive species in sickle cell disease. Ann NY Acad Sci 899: 375-391, 2000.
4. Baldus S, Eiserich JP, Brennan ML, Jackson RM, Alexander CB, and Freeman BA. Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases. Free Radic Biol Med 33: 1010-1019, 2002.
5. Baldus S, Eiserich JP, Mani A, Castro L, Figueroa M, Chumley P, Ma W, Tousson A, White CR, Bullard DC, Brennan ML, Lusis AJ, Moore KP, and Freeman BA. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest 108: 1759-1770, 2001.
6. Beckmann JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, and White CR. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler 375: 81-88, 1994.
7. Beuzard Y. Transgenic mouse models of sickle cell disease. Curr Opin Hematol 3: 150-155, 1996.
8. Bucci M, Roviezzo F, Cicala C, Sessa WC, and Cirino G. Geldanamycin, an inhibitor of heat shock protein 90 (Hsp90) mediated signal transduction has anti-inflammatory effects and interacts with glucocorticoid receptor in vivo. Br J Pharmacol 131: 13-16, 2000.
9. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med 337:762-769, 1997.
10. Burke TM and Wolin MS. Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. Am J Physiol Heart Circ Physiol 252: H721-H732, 1987.
11. Dias-Da Motta P, Arruda VR, Muscara MN, Saad ST, De Nucci G, Costa FF, and Condino-Neto A. The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anaemia. Br J Haematol 93: 333-340, 1996.
12. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, and van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391: 393-397, 1998.
13. Fabry ME, Suzuka SM, Weinberg RS, Lawrence C, Factor SM, Gilman JG, Costantini F, and Nagel RL. Second generation knockout sickle mice: the effect of HbF. Blood 97: 410-418, 2001.
14. Fontana J, Fulton D, Chen Y, Fairchild TA, McCabe TJ, Fujita N, Tsuruo T, and Sessa WC. Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ Res 90: 866-873, 2002.
15. French JA II, Kenny D, Scott JP, Hoffmann RG, Wood JD, Hudetz AG, and Hillery CA. Mechanisms of stroke in sickle cell disease: sickle erythrocytes decrease cerebral blood flow in rats after nitric oxide synthase inhibition. Blood 89: 4591-4599, 1997.
16. Fukuto JM and Mayer B. The enzymology of nitric oxide synthase. In: Methods in Nitric Oxide Research, edited by Feelisch M and Stamler JS. New York: Wiley, 1996, p. 145-160.
17. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, and Sessa WC. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 392: 821-824, 1998.
18. Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 39: 1529-1542, 1998.
19. Gladwin MT, Schechter AN, Shelhamer JH, Pannell LK, Conway DA, Hrinczenko BW, Nichols JS, Pease-Fye ME, Noguchi CT, Rodgers GP, and Ognibene FP. Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity. J Clin Invest 104: 937-945, 1999.
20. Govers R and Rabelink TJ. Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol 280: F193-F206, 2001.
21. Gratton JP, Fontana J, O'Connor DS, Garcia-Cardena G, McCabe TJ, and Sessa WC. Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro. Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1. J Biol Chem 275: 22268-22272, 2000.
22. Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett 411: 157-160, 1997.
23. Hammerman SI, Klings ES, Hendra KP, Upchurch GR Jr, Rishikof DC, Loscalzo J, and Farber HW. Endothelial cell nitric oxide production in acute chest syndrome. Am J Physiol Heart Circ Physiol 277: H1579-H1592, 1999.
24. Head CA, Brugnara C, Martinez-Ruiz R, Kacmarek RM, Bridges KR, Kuter D, Bloch KD, and Zapol WM. Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo. J Clin Invest 100: 1193-1198, 1997.
25. Hebbel RP, Eaton JW, Balasingam M, and Steinberg MH. Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest 70: 1253-1259, 1982.
26. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J 281: 627-630, 1992.
27. Hillery CA. Potential therapeutic approaches for the treatment of vaso-occlusion in sickle cell disease. Curr Opin Hematol 5: 151-155, 1998.
28. Ischiropoulos H, Zhu L, Chen J, Tsai M, Martin JC, Smith CD, and Beckman JS. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 298: 431-437, 1992.
29. Kaul DK, Fabry ME, Costantini F, Rubin EM, and Nagel RL. In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse. J Clin Invest 96: 2845-2853, 1995.
30. Kaul DK and Hebbel RP. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest 106: 411-420, 2000.
31. Kettle AJ, van Dalen CJ, and Winterbourn CC. Peroxynitrite and myeloperoxidase leave the same footprint in protein nitration. Redox Rep 3: 257-258, 1997.
32. Khurana VG, Feterik K, Springett MJ, Eguchi D, Shah V, and Katusic ZS. Functional interdependence and colocalization of endothelial nitric oxide synthase and heat shock protein 90 in cerebral arteries. J Cereb Blood Flow Metab 20: 1563-1570, 2000.
33. Koshida R, Ou J, Matsunaga T, Chilian WM, Oldham KT, Ackerman AW, and Pritchard KA Jr. Angiostatin, a negative regulator of endothelial function. Circulation 107: 803-806, 2003.
34. Moncada S and Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 9: 1319-1330, 1995.
35. Nath KA, Shah V, Haggard JJ, Croatt AJ, Smith LA, Hebbel RP, and Katusic ZS. Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease. Am J Physiol Regul Integr Comp Physiol 279: R1949-R1955, 2000.
36. Noguchi CT, Gladwin M, Diwan B, Merciris P, Smith R, Yu X, Buzard G, Fitzhugh A, Keefer LK, Schechter AN, and Mohandas N. Pathophysiology of a sickle cell trait mouse model: human alpha(beta)(S) transgenes with one mouse beta-globin allele. Blood Cells Mol Dis 27: 971-977, 2001.
37. Osarogiagbon UR, Choong S, Belcher JD, Vercellotti GM, Paller MS, and Hebbel RP. Reperfusion injury pathophysiology in sickle transgenic mice. Blood 96: 314-320, 2000.
38. Ou J, Ou Z, Ackerman AW, Oldham KT, and Pritchard KA Jr. Inhibition of heat shock protein 90 (hsp90) in proliferating endothelial cells uncouples endothelial nitric oxide synthase activity. Free Radic Biol Med 34: 269-276, 2003.
39. Ou J, Ou Z, Ackerman AW, Oldham KT, and Pritchard KA Jr. Inhibition of heat shock protein 90 (hsp90) in proliferating endothelial cells uncouples endothelial nitric oxide synthase activity. Free Radic Biol Med 34: 269-276, 2003.
40. Ou J, Ou Z, Jones DW, Holzman S, Hatoum OA, Ackerman AW, Weihrauch DW, Gutterman DD, Guice K, Oldham KT, Hillery CA, and Pritchard KA Jr. L-4F, an apo A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease. Circulation 107: r84-r88, 2003.
41. Paszty C, Brion CM, Manci E, Witkowska HE, Stevens ME, Mohandas N, and Rubin EM. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science 278: 876-878, 1997.
42. Pritchard KA Jr, Ackerman AW, Gross ER, Stepp DW, Shi Y, Fontana JT, Baker JE, and Sessa WC. Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J Biol Chem 276: 17621-17624, 2001.
43. Pritchard KA Jr, Ackerman AW, Ou J, Smalley DM, Curtis ML, Fontana JT, Stemerman MB, and Sessa WC. Native low-density lipoprotein induces endothelial nitric oxide synthase dysfunction: role of heat shock protein 90 and caveolin-1. Free Radic Biol Med 33: 52-62, 2002.
44. Radi R, Beckman JS, Bush KM, and Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288: 481-487, 1991.
45. Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO III, Schechter AN, and Gladwin MT. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 8: 1383-1389, 2002.
46. Sawa T, Akaike T, and Maeda H. Tyrosine nitration by peroxynitrite formed from nitric oxide and superoxide generated by xanthine oxidase. J Biol Chem 275: 32467-32474, 2000.
47. Shah V, Wiest R, Garcia-Cardena G, Cadelina G, Groszmann RJ, and Sessa WC. Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension. Am J Physiol Gastrointest Liver Physiol 277: G463-G468, 1999.
48. Shi Y, Baker JE, Zhang C, Tweddell JS, Su J, and Pritchard KA Jr. Chronic hypoxia increases endothelial nitric oxide synthase generation of nitric oxide by increasing heat shock protein 90 association and serine phosphorylation. Circ Res 91: 300-306, 2002.
49. Shi Y, Pritchard KA, Holman P, Rafiee P, Griffith OW, Kalyanaraman B, and Baker JE. Chronic myocardial hypoxia increases nitric oxide synthase and decreases caveolin-3. Free Radic Biol Med 29: 695-703, 2000.
50. Song Y, Cardounel AJ, Zweier JL, and Xia Y. Inhibition of superoxide generation from neuronal nitric oxide synthase by heat shock protein 90: implications in NOS regulation. Biochemistry 41: 10616-10622, 2002.
51. Song Y, Zweier JL, and Xia Y. Determination of the enhancing action of HSP90 on neuronal nitric oxide synthase by EPR spectroscopy. Am J Physiol Cell Physiol 281: C1819-C1824, 2001.
52. Stepp DW, Ou J, Ackerman AW, Welak S, Klick D, and Pritchard KA Jr. Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ. Am J Physiol Heart Circ Physiol 283: H750-H759, 2002.
53. Su Y and Block ER. Role of calpain in hypoxic inhibition of nitric oxide synthase activity in pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol 278: L1204-L1212, 2000.
54. Van der Vliet A, Eiserich JP, Halliwell B, and Cross CE. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem 272: 7617-7625, 1997.
55. Wang J, Stuehr DJ, Ikeda-Saito M, and Rousseau DL. Heme coordination and structure of the catalytic site in nitric oxide synthase. J Biol Chem 268: 22255-22258, 1993.
56. White CR, Darley-Usmar V, Berrington WR, McAdams M, Gore JZ, Thompson JA, Parks DA, Tarpey MM, and Freeman BA. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci USA 93: 8745-8749, 1996.
57. Whitney JB III. Simplified typing of mouse hemoglobin (Hbb) pheno-types using cystamine. Biochem Genet 16: 667-672, 1978.
58. Wolin MS and Burke TM. Hydrogen peroxide elicits activation of bovine pulmonary arterial soluble guanylate cyclase by a mechanism associated with its metabolism by catalase. Biochem Biophys Res Commun 143: 20-25, 1987.
59. Zhang H, Bhargava K, Keszler A, Feix J, Hogg N, Joseph J, and Kalyanaraman B. Transmembrane nitration of hydrophobic tyrosyl peptides. Localization, characterization, mechanism of nitration, and biological implications. J Biol Chem 278: 8969-8978, 2003.
60. Zhang H, Joseph J, Feix J, Hogg N, and Kalyanaraman B. Nitration and oxidation of a hydrophobic tyrosine probe by peroxynitrite in membranes: comparison with nitration and oxidation of tyrosine by peroxynitrite in aqueous solution. Biochemistry 40: 7675-7686, 2001.